These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 8550361)
1. Long-term efficacy of subcutaneous sumatriptan using a novel self-injector. Gross ML; Kay J; Turner AM; Jewsbury J; Cleal AL Headache; 1995; 35(10):601-6. PubMed ID: 8550361 [TBL] [Abstract][Full Text] [Related]
2. Sumatriptan in acute migraine using a novel cartridge system self-injector. United Kingdom Study Group. Gross ML; Kay J; Turner AM; Hallett K; Cleal AL; Hassani H Headache; 1994; 34(10):559-63. PubMed ID: 7843948 [TBL] [Abstract][Full Text] [Related]
3. An open-label trial of a sumatriptan auto-injector for migraine in patients currently treated with subcutaneous sumatriptan. Landy SH; Tepper SJ; Wein T; Schweizer E; Ramos E Headache; 2013 Jan; 53(1):118-125. PubMed ID: 23148799 [TBL] [Abstract][Full Text] [Related]
4. Open-labeled long-term study of the efficacy, safety, and tolerability of subcutaneous sumatriptan in acute migraine treatment. Göbel H; Heinze A; Stolze H; Heinze-Kuhn K; Lindner V Cephalalgia; 1999 Sep; 19(7):676-83; discussion 626. PubMed ID: 10524662 [TBL] [Abstract][Full Text] [Related]
5. Introduction of a novel self-injector for sumatriptan. A controlled clinical trial in general practice. Jensen K; Tfelt-Hansen P; Hansen EW; Krøis EH; Pedersen OS Cephalalgia; 1995 Oct; 15(5):423-9. PubMed ID: 8536304 [TBL] [Abstract][Full Text] [Related]
6. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine. Winner P; Ricalde O; Le Force B; Saper J; Margul B Arch Neurol; 1996 Feb; 53(2):180-4. PubMed ID: 8639069 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of subcutaneous sumatriptan in the acute treatment of early-morning migraine: a placebo-controlled trial. Early-Morning Migraine Sumatriptan Study Group. Bousser MG; D'Allens H; Richard A J Intern Med; 1993 Aug; 234(2):211-6. PubMed ID: 8393474 [TBL] [Abstract][Full Text] [Related]
8. An open study of self-administration of subcutaneous sumatriptan to treat successive attacks of acute migraine. Portuguese Sumatriptan Auto-injector Study Group. J Int Med Res; 1994; 22(4):225-35. PubMed ID: 7958382 [TBL] [Abstract][Full Text] [Related]
9. Subcutaneous sumatriptan in the acute treatment of migraine in patients using dihydroergotamine as prophylaxis. French Migraine Network Bordeaux-Lyon-Grenoble. Henry P; d'Allens H Headache; 1993 Sep; 33(8):432-5. PubMed ID: 8262783 [TBL] [Abstract][Full Text] [Related]
10. The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. The Sumatriptan Menstrual Migraine Study Group. Facchinetti F; Bonellie G; Kangasniemi P; Pascual J; Shuaib A Obstet Gynecol; 1995 Dec; 86(6):911-6. PubMed ID: 7501338 [TBL] [Abstract][Full Text] [Related]
11. Oral and subcutaneous sumatriptan in the acute treatment of migraine: an open randomized cross-over study. Carpay HA; Matthijsse P; Steinbuch M; Mulder PG Cephalalgia; 1997 Aug; 17(5):591-5. PubMed ID: 9251875 [TBL] [Abstract][Full Text] [Related]
12. Self-treatment of acute migraine with subcutaneous sumatriptan using an auto-injector device: comparison with customary treatment in an open, longitudinal study. Schoenen J; Bulcke J; Caekebeke J; Dehaene I; De Keyser J; Hildebrand G; Joffroy A; Laloux P; Louis P; Monseu G Cephalalgia; 1994 Feb; 14(1):55-63. PubMed ID: 8200027 [TBL] [Abstract][Full Text] [Related]
13. Practicability and acceptance of subcutaneous self-administration of the selective serotonin agonist sumatriptan. Göbel H; Baar H; Beiküfner HD; Böhme K; Beckmann-Reinhold A Headache; 1998 Apr; 38(4):267-9. PubMed ID: 9595865 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of sumatriptan in reducing productivity loss due to migraine: results of a randomized, double-blind, placebo-controlled clinical trial. Schulman EA; Cady RK; Henry D; Batenhorst AS; Putnam DG; Watson CB; O'Quinn SO Mayo Clin Proc; 2000 Aug; 75(8):782-9. PubMed ID: 10943230 [TBL] [Abstract][Full Text] [Related]
15. Sumatriptan nasal spray for the acute treatment of migraine. Results of two clinical studies. Ryan R; Elkind A; Baker CC; Mullican W; DeBussey S; Asgharnejad M Neurology; 1997 Nov; 49(5):1225-30. PubMed ID: 9371898 [TBL] [Abstract][Full Text] [Related]
16. [18 months long-term analysis of effectiveness, safety and tolerance of sumatriptan s.c. in acute therapy of migraine attacks]. Göbel H; Stolze H; Heinze A; Dworschak M; Heuss D; Christiani K; Lindner V Nervenarzt; 1996 Jun; 67(6):471-83. PubMed ID: 8767202 [TBL] [Abstract][Full Text] [Related]
17. An open-label study to assess changes in efficacy and satisfaction with migraine care when patients have access to multiple sumatriptan succinate formulations. Weidmann E; Unger J; Blair S; Friesen C; Hart C; Cady R Clin Ther; 2003 Jan; 25(1):235-46. PubMed ID: 12637123 [TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of subcutaneous sumatriptan for acute migraine: a comparison between ethnic groups. Burke-Ramirez P; Asgharnejad M; Webster C; Davis R; Laurenza A Headache; 2001 Oct; 41(9):873-82. PubMed ID: 11703474 [TBL] [Abstract][Full Text] [Related]
19. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial. Dowson AJ; Charlesworth BR; Purdy A; Becker WJ; Boes-Hansen S; Färkkilä M CNS Drugs; 2003; 17(11):839-51. PubMed ID: 12921494 [TBL] [Abstract][Full Text] [Related]
20. Satisfaction with and confidence in needle-free subcutaneous sumatriptan in patients currently treated with triptans. Cady RK; Aurora SK; Brandes JL; Rothrock JF; Myers JA; Fox AW; Farr SJ Headache; 2011 Sep; 51(8):1202-11. PubMed ID: 21812775 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]